全文获取类型
收费全文 | 37867篇 |
免费 | 2901篇 |
国内免费 | 121篇 |
专业分类
耳鼻咽喉 | 365篇 |
儿科学 | 1037篇 |
妇产科学 | 690篇 |
基础医学 | 5477篇 |
口腔科学 | 648篇 |
临床医学 | 3968篇 |
内科学 | 8093篇 |
皮肤病学 | 777篇 |
神经病学 | 3881篇 |
特种医学 | 1389篇 |
外国民族医学 | 11篇 |
外科学 | 5263篇 |
综合类 | 437篇 |
一般理论 | 30篇 |
预防医学 | 3093篇 |
眼科学 | 727篇 |
药学 | 2650篇 |
中国医学 | 93篇 |
肿瘤学 | 2260篇 |
出版年
2023年 | 292篇 |
2022年 | 416篇 |
2021年 | 975篇 |
2020年 | 675篇 |
2019年 | 900篇 |
2018年 | 1073篇 |
2017年 | 860篇 |
2016年 | 967篇 |
2015年 | 1018篇 |
2014年 | 1390篇 |
2013年 | 1717篇 |
2012年 | 2696篇 |
2011年 | 2806篇 |
2010年 | 1590篇 |
2009年 | 1315篇 |
2008年 | 2147篇 |
2007年 | 2298篇 |
2006年 | 2192篇 |
2005年 | 1983篇 |
2004年 | 1879篇 |
2003年 | 1577篇 |
2002年 | 1477篇 |
2001年 | 616篇 |
2000年 | 627篇 |
1999年 | 562篇 |
1998年 | 341篇 |
1997年 | 258篇 |
1996年 | 258篇 |
1995年 | 227篇 |
1994年 | 194篇 |
1993年 | 149篇 |
1992年 | 324篇 |
1991年 | 301篇 |
1990年 | 309篇 |
1989年 | 249篇 |
1988年 | 252篇 |
1987年 | 274篇 |
1986年 | 288篇 |
1985年 | 272篇 |
1984年 | 226篇 |
1983年 | 178篇 |
1982年 | 125篇 |
1979年 | 240篇 |
1978年 | 161篇 |
1977年 | 140篇 |
1975年 | 122篇 |
1974年 | 131篇 |
1973年 | 138篇 |
1972年 | 123篇 |
1971年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
991.
992.
993.
994.
995.
996.
Huw B. Jones Jaimini Reens Simon R. Brocklehurst Catherine J. Betts Sue Bickerton Alison L. Bigley Richard P. Jenkins Nicky M. Whalley Derrick Morgan David M. Smith 《International journal of experimental pathology》2014,95(1):29-48
Antagonism of the effects of glucagon as an adjunct therapy with other glucose‐lowering drugs in the chronic treatment of diabetes has been suggested to aggressively control blood glucose levels. Antagonism of glucagon effects, by targeting glucagon secretion or disabling the glucagon receptor, is associated with α‐cell hyperplasia. We evaluated the influence of total glucagon withdrawal on islets of Langerhans using prohormone convertase‐2 knockout mice (PC2‐ko), in which α‐cell hyperplasia is present from a young age and persists throughout life, in order to understand whether or not sustained glucagon deficit would lead to islet tumorigenesis. PC2‐ko and wild‐type (WT) mice were maintained drug‐free, and cohorts of these groups sampled at 3, 12 and 18 months for plasma biochemical and morphological (histological, immunohistochemical, electron microscopical and image analytical) assessments. WT mice showed no islet tumours up to termination of the study, but PC2‐ko animals displayed marked changes in islet morphology from α‐cell hypertrophy/hyperplasia/atypical hyperplasia, to adenomas and carcinomas, these latter being first encountered at 6–8 months. Islet hyperplasias and tumours primarily consisted of α‐cells associated to varying degrees with other islet endocrine cell types. In addition to substantial increases in islet neoplasia, increased α‐cell neogenesis associated primarily with pancreatic duct(ule)s was present. We conclude that absolute blockade of the glucagon signal results in tumorigenesis and that the PC2‐ko mouse represents a valuable model for investigation of islet tumours and pancreatic ductal neogenesis. 相似文献
997.
998.
999.
Lin Zhang Joseph JY Sung Jun Yu Siew C Ng Sunny H Wong Chi H Cho Simon SM Ng Francis KL Chan William KK Wu 《The Journal of pathology》2014,233(2):103-112
Helicobacter pylori and Epstein–Barr virus (EBV) account for roughly 80% and 10%, respectively, of gastric carcinomas worldwide. Autophagy is an evolutionarily conserved and intricately regulated cellular process that involves the sequestration of cytoplasmic proteins and organelles into double‐membrane autophagosomes that eventually fuse with lysosomes for degradation of the engulfed content. Emerging evidence indicates that xenophagy, a form of selective autophagy, plays a crucial role in the pathogenesis of H. pylori‐ and EBV‐induced gastric cancer. Xenophagy specifically recognizes intracellular H. pylori and EBV and physically targets these pathogens to the autophagosomal–lysosomal pathway for degradation. In this connection, H. pylori or EBV‐induced dysregulation of autophagy may be causally linked to gastric tumourigenesis and therefore can be exploited as therapeutic targets. This review will discuss how H. pylori and EBV infection activate autophagy and how these pathogens evade recognition and degradation by the autophagic pathway. Elucidating the molecular aspects of H. pylori‐ and EBV‐induced autophagy will help us better understand the pathogenesis of gastric cancer and promote the development of autophagy modulators as antimicrobial agents. Published by John Wiley & Sons, Ltd 相似文献
1000.
Mandeep Singh Ruchi Jha Jonathan Melamed Ellen Shapiro Simon W. Hayward Peng Lee 《The American journal of pathology》2014,184(10):2598-2607
The androgen receptor (AR) in stromal cells contributes significantly to the development and growth of prostate during fetal stages as well as during prostate carcinogenesis and cancer progression. During prostate development, stromal AR induces and promotes epithelial cell growth, as observed from tissue recombinant and mouse knockout studies. During prostate carcinogenesis and progression, the stromal cells begin to lose AR expression as early as at the stage of high-grade prostatic intraepithelial neoplasia. The extent of loss of stromal AR is directly proportional to the degree of differentiation (Gleason grade) and progression of prostate cancer (PCa). Co-culture studies suggested that stromal AR inhibits the growth of malignant epithelial cells, possibly through expression of certain paracrine factors in the presence of androgens. This functional reversal of stromal AR, from growth promotion during fetal prostate development to mediating certain growth-inhibiting effects in cancer, explains to some extent the reason that loss of AR expression in stromal cells may be crucial for development of resistance to androgen ablation therapy for PCa. From a translational perspective, it generates the need to re-examine the current therapeutic options and opens a fundamental new direction for therapeutic interventions, especially in advanced PCa.CME Accreditation Statement: This activity (“ASIP 2014 AJP CME Program in Pathogenesis”) has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.The ASCP designates this journal-based CME activity (“ASIP 2014 AJP CME Program in Pathogenesis”) for a maximum of 48 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.CME Disclosures: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.Prostate cancer (PCa) is the most common non-skin malignancy in the male population within the United States and is the second most common cancer in men worldwide.1 It is also one of the leading causes of cancer-related deaths in males in the United States.Normal human prostate is composed of an epithelial tissue and an adjacent stroma. The epithelium is composed of two principal cell types, the tall columnar secretory luminal cells that line the glandular ducts and the flattened basal cells surrounding them. In addition, some rare neuroendocrine cells are also present. Often, the terms mesenchyme and stroma are loosely used. Herein, mesenchyme refers to the mesodermal-derived fetal or newborn tissues with instructive induction potential. The word stroma describes the tissues surrounding the prostatic epithelium, later in development. In the adult human prostate, the stroma is composed mainly of smooth muscle cells. However, it also includes some fibroblasts, nerves, blood vessels, and various infiltrating immune and inflammatory cell types.Circulating androgens mediate the development and function of prostate by stimulating the androgen receptor (AR). Rat studies have shown that in stroma, AR is expressed in mesenchymal cells of the urogenital sinus (UGS), especially those adjacent to the epithelium, concurrent with the formation of prostatic buds.2,3 As the prostate develops and the mesenchymal cells differentiate to form smooth muscle, AR expression is widespread, but not universal, throughout the muscle. In the past, investigators have mainly focused on studying epithelial AR function in prostate. Relatively limited data are available to describe the expression and function of stromal AR in prostate development2–14 and cancer. Stromal AR is involved in both prostate development and prostate carcinogenesis, with distinct functions in these two processes. We examine the current knowledge and understanding of stromal AR function, including its translational significance. 相似文献